EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark NORTHERA was filed as Word mark on 05/18/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/21/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018474196 |
| Application date | May 18, 2021 |
| Publication date | June 14, 2021 |
| Entry date | September 21, 2021 |
| Expiration date | May 18, 2031 |
Trademark owner
Ottiliavej 9
2500 Valby
DK
2500 Valby
DK
goods and services
5
Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, dementia, Alzheimer's disorder and disease, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease; pharmaceutical preparations and substances used for the prevention, management and treatment of falls, movement disorders and diseases, dyskinesia; poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), agitation, aggression, autism, melancholy, obsessive-compulsive disorder (OCD), Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension (NOH), low blood pressure, dizziness, lightheadedness gait stiffness; preparations, substances, reagents and agents for diagnostic and medical purposes
ID: 11018474196